References
- Akiyama Y, Watkins N, Suzuki H, et al (2003). GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol, 23, 8429. https://doi.org/10.1128/MCB.23.23.8429-8439.2003
- Behrens P, Brinkmann U, Fogt F, Wernert N, Wellmann A (2001). Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer Res, 21, 2413-7.
- Behrens P, Brinkmann U, Wellmann A (2003). CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis, 8, 39-44. https://doi.org/10.1023/A:1021644918117
- Bera TK, Bera J, Brinkmann U, Tessarollo L, Pastan I (2001). Cse1l is essential for early embryonic growth and development. Mol Cell Biol, 21, 7020-4. https://doi.org/10.1128/MCB.21.20.7020-7024.2001
- Brinkmann U, Brinkmann E, Bera TK, Wellmann A, Pastan I (1999). Tissue-Specific Alternative Splicing of the CSE1L/CAS (Cellular Apoptosis Susceptibility) Gene* 1. Genomics, 58, 41-9. https://doi.org/10.1006/geno.1998.5700
- Castanotto D, Rossi JJ (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature, 457, 426-33. https://doi.org/10.1038/nature07758
- Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S (2011). Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer, 11, 371. https://doi.org/10.1186/1471-2407-11-371
- Eberhart CE, Coffey R, Radhika A, et al (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183.
- Kim JG, Chae YS, Sohn SK, et al (2008). Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res, 14, 62. https://doi.org/10.1158/1078-0432.CCR-07-1537
- Liao CF, Luo SF, Shen TY, et al (2008). CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB Rep, 41, 210-6. https://doi.org/10.5483/BMBRep.2008.41.3.210
- Liao CF, Luo SF, Li LT, et al (2008). CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J Exp Clin Canc Res, 27, 15. https://doi.org/10.1186/1756-9966-27-15
- Mulkeen AL, Silva T, Yoo PS, et al (2006). Short Interfering RNA-Mediated Gene Silencing of Vascular Endothelial Growth Factor: Effects on Cellular Proliferation in Colon Cancer Cells. Arch Surg, 141, 367-74. https://doi.org/10.1001/archsurg.141.4.367
- O'Brien CA, Pollett A, Gallinger S, Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-10. https://doi.org/10.1038/nature05372
- Pai SI, Lin YY, Macaes B, et al (2005). Prospects of RNA interference therapy for cancer. Gene Ther, 13, 464-77.
- Suzuki H, Watkins DN, Jair KW, et al (2004). Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet, 36, 417-22. https://doi.org/10.1038/ng1330
- Tai CJ, Shen SC, Lee WR, et al (2010). Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res, 316, 2969-81. https://doi.org/10.1016/j.yexcr.2010.07.019
- Tsao TY, Tsai CS, Tung JN, et al (2009a). Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biocheml, 327, 163-70. https://doi.org/10.1007/s11010-009-0054-0
- Tsao TY, Tsai CSS, Tung JN, et al (2009b). Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biocheml, 327, 163-70. https://doi.org/10.1007/s11010-009-0054-0
- Tung MC, Tsai CSS, Tung JN, et al (2009). Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. Cancer Epidem Biomar, 18, 1570. https://doi.org/10.1158/1055-9965.EPI-08-0948
- Wellmann A, Flemming P, Behrens P, et al (2001). High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. Int J Mol Med, 7, 489.
- Zhang S, Yang JH, Guo CK, Cai P (2007). Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett, 253, 108-14. https://doi.org/10.1016/j.canlet.2007.01.010
Cited by
- Lack of Relation of AKAP12 with p53 and Bcl-2 in Colorectal Carcinoma vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3415
- The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer Therapy vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0163983
- Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation vol.13, pp.6, 2016, https://doi.org/10.3892/mmr.2016.5200
- CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5301-x
- Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential vol.68, pp.4, 2016, https://doi.org/10.1002/iub.1484
- Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett’s Esophagus pp.1541-2016, 2018, https://doi.org/10.1097/PAI.0000000000000464
- CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival vol.7, pp.1, 2017, https://doi.org/10.1038/srep46238
- CSE1L participates in regulating cell mitosis in human seminoma pp.09607722, 2018, https://doi.org/10.1111/cpr.12549
- Positive Caricature Transcriptomic Effects Associated with Broad Genomic Aberrations in Colorectal Cancer vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-32884-3
- Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing vol.115, pp.17, 2018, https://doi.org/10.1073/pnas.1800505115